ChemGenix Of Australia Reports Good Results For Leukemia Drug
This article was originally published in PharmAsia News
Executive Summary
Australia's ChemGenix Pharmaceuticals says its Omapro (omacetaxine) has proven effective in 86 percent of patients with chronic myeloid leukemia who failed previous treatment